Cobalt 27 Capital (KBLT) Stock Price, News & Analysis

Company Overview

Cobalt 27 Capital Corp. operates as a minerals company. It holds physical cobalt material; owns a cobalt stream on Vale's worldclass Voisey's Bay mine; and manages a portfolio of nine royalties, as well as intends to invest in a cobalt-focused portfolio of streams, royalties, and direct interests in mineral properties containing cobalt. The company was formerly known as Arak Resources Ltd. and changed its name to Cobalt 27 Capital Corp. in April 2017. Cobalt 27 Capital Corp. was incorporated in 2006 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$4.36 to C$4.38
• 50-Day Range: C$4.36 to C$4.36
• 52-Week Range: C$3.27 to C$6.90
• Volume: 7,023 shs
• Average Volume: 331,766 shs
• Market Capitalization: C$372.67 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KBLT Stock Analysis - Frequently Asked Questions

How have KBLT shares performed this year?

Cobalt 27 Capital's stock was trading at C$4.36 at the beginning of the year. Since then, KBLT shares have increased by 0.0% and is now trading at C$4.36.
View the best growth stocks for 2024 here.

How do I buy shares of Cobalt 27 Capital?

Shares of KBLT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Cobalt 27 Capital own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cobalt 27 Capital investors own include QUALCOMM (QCOM), Neo Lithium (NLC), Aurora Cannabis (ACB), Advanced Micro Devices (AMD), Alibaba Group (BABA), Bombardier, Inc. Class B (BBD.B) and Editas Medicine (EDIT).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Basic Materials
• Industry: Industrial Metals & Minerals
• Sub-Industry: N/A
• Current Symbol: CVE:KBLT
• Previous Symbol: CVE:AAC
• CUSIP: N/A
• CIK: N/A
• Web: www.co27.com
• Phone: +1-647-8467765
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 42.12
• Current Ratio: 2.10
• Quick Ratio: 2.08

Sales & Book Value

• Annual Sales: C$-167,719,456.00
• Price / Sales: -2.22
• Cash Flow: C$0.26 per share
• Price / Cash Flow: 16.90
• Book Value: C$4.63 per share
• Price / Book: 0.94

Miscellaneous

• Outstanding Shares: 85,475,000
• Free Float: N/A
• Market Cap: C$372.67 million
• Optionable: Not Optionable
• Beta: N/A